Testing time for telomeres. Telomere length can tell us something about disease susceptibility and ageing, but are commercial tests ready for prime time?

EMBO Reports

Volumn 12, Issue 9, 2011, Pages 897-900

  Wolinsky, Howard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TELOMERASE;

AGING; ARTICLE; BIOETHICS; BLOOD ANALYSIS; BLOOD SAMPLING; CHROMOSOME ANALYSIS; CHROMOSOME STRUCTURE; CLINICAL RESEARCH; CYTOLOGY; DIAGNOSTIC ACCURACY; DISEASE PREDISPOSITION; DNA SEQUENCE; HEALTH; HUMAN; INTERVENTION STUDY; LABORATORY TEST; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; LONGEVITY; PHYSICIAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SCIENTIST; TELOMERE; TELOMERE LENGTH;

AGING; BIOLOGICAL MARKERS; DISEASE SUSCEPTIBILITY; HUMANS; LONGEVITY; MOLECULAR DIAGNOSTIC TECHNIQUES; TELOMERE;

EID: 80052300272     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2011.166     Document Type: Article

References (7)

1. Blackburn EH, Gall JG (1978) A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genesin Tetrahymena. J Mol Biol 120: 33-53 (Pubitemid 8312910)
2. Connor S (2011) The £400 test that tells you how long you'll live. The Independent 16 May.
3. de Jesus B et al (2011) The telomerase activator TA-TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence. Aging Cell 10: 604-621
4. Harley CB, Liu W, Blasco M, Vera E, Andrews WH,Briggs LA, Raffaele JM (2011) A natural product telomerase activator as part of a health maintenance program. Rejuvenation Res 14: 45-56
5. Olovnikov AM (1973) A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon.J Theor Biol 41: 181-190
6. Szostak JW, Blackburn EH (1982) Cloning yeast telomeres on linear plasmid vectors. Cell 29: 245-255 (Pubitemid 12027686)
7. Willeit P et al (2010) Telomere length and risk of incident cancer and cancer mortality. JAMA 304: 69-75